Preface | p. vii |
Foreword | p. ix |
Foundations | |
Historical Perspectives | p. 1 |
Epidemiology-The United States | p. 17 |
Epidemiology-A European Perspective | p. 26 |
Determinants of Abuse and Dependence | |
Genetic Factors in the Risk for Substance Use Disorders | |
Neurobiological Factors of Drug Dependence and Addiction | p. 55 |
Psychological Factors (In Determinants of Abuse and Dependence) | p. 79 |
Behavioral Aspects | p. 88 |
Sociocultural Factors and Their Implications | p. 99 |
Evaluation | |
Clinical Assessment | p. 117 |
Diagnosis and Classification: DSM-IV-TR and ICD-10 | p. 117 |
Diagnostic Laboratory: Screening for Drug Abuse....123 | |
Substances of Abuse | |
Alcohol Use Disorders | p. 138 |
Opioids | p. 161 |
Cocaine and Crack | p. 191 |
Cannabis | p. 214 |
Amphetamines and Other Stimulants | p. 238 |
Sedative-Hypnotics | p. 255 |
Hallucinogens | p. 267 |
PCP/Designer Drugs/MDMA | p. 277 |
Inhalants | p. 284 |
Nicotine | p. 319 |
Caffeine | p. 335 |
Anabolic-Androgenic Steroids | p. 354 |
Compulsive and Addictive Behaviors | |
Eating Disorders and Substance Use Disorders | p. 373 |
Pathologic Gambling | p. 384 |
Sexual Addiction | p. 393 |
Internet Addiction | p. 284 |
Treatment Approaches | |
Neurobiologic Treatments | |
Methadone Maintenance | p. 419 |
Buprenorphine in the Treatment of Opioid Dependence | p. 437 |
Naltrexone Pharmacotherapy | p. 447 |
Vaccines for Substance Abuse | p. 457 |
Acupuncture | p. 466 |
Alcohol Abstinence Management | p. 477 |
Alternative Pharmacotherapies for Opioid Addiction | p. 494 |
Sedative-Hypnotics Abstinence | p. 501 |
Nicotine Dependence Management | p. 510 |
Psychosocial and Other Treatments | |
Self-Help Programs Focused on Substance Use: Active Ingredients and Outcomes | p. 523 |
Alternative Support Groups | p. 533 |
The Therapeutic Community | p. 543 |
Network Therapy | p. 551 |
Individual Psychotherapy | p. 562 |
Group Therapy | p. 575 |
Family/Couples Approaches to Treatment Engagement and Therapy | p. 584 |
Cognitive Behavioral Therapy | p. 593 |
Contingency Management in the Treatment of Substance Use Disorders: Trends in the Literature | p. 603 |
Motivational Interviewing and Enhancement | p. 622 |
Relapse Prevention | p. 633 |
Management of Associated Medical Conditions | |
Maternal and Neonatal Complications of Alcohol and Other Drugs | p. 648 |
Medical Complications of Drug Use/Dependence | p. 663 |
Psychiatric Complications of HIV-1 Infection and Drug Abuse | p. 682 |
Acute and Chronic Pain | p. 695 |
Substance Use Disorders in Individuals with Co-occurring Psychiatric Disorders | p. 721 |
Medication Interactions | p. 730 |
Models of Prevention | |
School-Based Programs | p. 742 |
Harm Reduction: New Drug Policies and Practices | p. 754 |
Work Setting | p. 777 |
Life Cycle | |
Adolescent Substance Abuse | p. 786 |
The Older Drug Abuser | p. 802 |
Special Populations | |
African Americans: Alcohol and Substance Abuse | p. 813 |
Hispanic Americans | p. 819 |
Asian Americans and Pacific Islanders | p. 829 |
American Indians and Alaska Natives | p. 837 |
Women and Addiction | p. 847 |
Gays, Lesbians, and Bisexuals | p. 871 |
Incarcerated Populations | p. 881 |
Substance Use Disorders among Health Care Professionals | p. 892 |
The Homeless | p. 901 |
Disability, Impairment, and Addiction | p. 908 |
New Immigrants and Refugees | p. 918 |
Substance Use in the Armed Forces | p. 926 |
Training and Education | |
Medical Education on Addiction | p. 937 |
Psychologists: Training and Education | p. 949 |
Nursing Education in Addictions and Substance Abuse | p. 957 |
Social Worker Education and Training in the Care of Persons with Substance Use Disorders | p. 965 |
Counselor Training and Education | p. 971 |
Other Mental Health Professionals | p. 979 |
Policy Issues | |
Drug Policy: A Biological Science Perspective | p. 988 |
Substance Abuse Policy and Payment | p. 1011 |
Forensics | p. 1019 |
Clinical and Societal Implications of Drug Legalization | p. 1034 |
Future Directions | p. 1046 |
Table of Contents provided by Publisher. All Rights Reserved. |